CBLN1 and myocardial infarction: In patients with acute myocardial infarction, 12 ceramide species were found to predict 12-month major adverse cardiovascular events, Cer(d18:1/24:1(15Z)), Cer(d18:1/22:1), and dihydroceramide (d18:0/16:0) being the most representative [26].